Skip to main content
. Author manuscript; available in PMC: 2020 Jul 15.
Published in final edited form as: Cancer Res. 2019 Nov 12;80(2):347–353. doi: 10.1158/0008-5472.CAN-19-0725

Table 2:

Number of primary cancer patients by the TP53 mutation status and Sex in the validation dataset with probands removed to address ascertainment bias: the MDACC prospective clinical cohort. Abbreviations: SPC, single primary cancer patients; MPC, multiple primary cancer patients.

Wildtype Mutation
Healthy individuals Male 114 40
Female 136 30
SPC Male 16 31
Female 12 43
MPC Male 1 21
Female 2 34
Total number of individuals 281 199